Is there a role for aromatic plants in blue tit (Cyanistes caeruleus) nests? Results from a correlational and an experimental study

Open access funding provided by FCT|FCCN (b-on). The research was financed by Fundação para a Ciência e a Tecnologia through the strategic program of MARE (MARE-UID/MAR/04292/2020), the project LA/P/0069/2020 granted to the Associate Laboratory ARNET, and the transitory norm contract DL57/2016/CP1370/CT89 to ACN. JG-B was supported by an AUIP Mobility Grant, by a FPU Pre-doctoral contract (FPU18/03034) from the Spanish Ministry of Education and by a research project of the National Plan of the Spanish Ministry of Economy and Competitiveness (CGL2017-84938-P). SIA was supported by ‘Programa de financiamiento parcial para estadías en el exterior para becarios postdoctorales’ from Argentinian National Scientific and Technical Research Council and ‘Becas de movilidad con perspectiva de género’ from Production, Science and Technology Ministry of Santa Fe Province, Argentina.The utility of fresh green material in avian nests is still not fully understood. Potential explanations include the effects of plants' volatile compounds on parasite reduction (nest protection hypothesis) or direct beneficial effects on nestling condition (drug hypothesis). We used correlative data collected during 2020 and 2021 in a Mediterranean population of blue tits (Cyanistes caeruleus) as well as experimental data (aromatic nest content manipulation) to assess the effects of aromatic plant use on nestling physiological condition and survival, nest-dwelling ectoparasitic pressure and its relationship with breeding parameters. We found that aromatic plants were disproportionally used in relation to their abundance in the environment and that their use was positively related to egg mass (but only in 2020). Blowflies and facultative parasitic mites were more frequent in nests with aromatics compared to nests without aromatics, but obligatory parasitic mites were less abundant in nests with aromatics. However, no effects of aromatic plants were observed on nestling haemoglobin levels nor erythrocyte sedimentation rate or other physiological health metrics, but the heterophil to lymphocyte ratio was higher in nests with the highest quantity of aromatics. The artificial addition of mint reduced the flea abundance, but 7-day old nestlings showed significantly lower colour saturation and brightness in the mouth flange. Nestling survival to fledging was not related to aromatic plant use. Therefore, our results partially support a beneficial effect of aromatic plants in blue tit nests because some ectoparasite groups were reduced. Immediate effects on nestling physiology or survival could not be established. Significance statement: Some avian species place fresh aromatic plant material in their nests, and several non-mutually exclusive hypotheses have been proposed to explain its potential functions. In this study, we use both correlational and experimental data from a blue tit population to test two hypotheses, namely the 'nest protection hypothesis' and the 'drug hypothesis'. The first one proposes that aromatic plants have direct repellent effects against ectoparasites, while the latter poses that these plant components benefit nestling condition through the stimulation of some components of the immune system. Our results suggest that some ectoparasites, such as fleas and obligatory parasitic mites, were less abundant in nests where aromatic plants were artificially or naturally added, respectively, but no relationships were detected with nestling physiology or survival, which could be partially explained by our small sample size. Our study partially supports a beneficial effect of aromatic plants in avian nests.FCT|FCCN (b-on)Fundação para a Ciência e a Tecnologia (MARE-UID/MAR/04292/2020)Associate Laboratory ARNET LA/P/0069/2020AUIP Mobility Grant DL57/2016/CP1370/CT89Spanish Ministry of Education (FPU18/03034)National Plan of the Spanish Ministry of Economy and Competitiveness (CGL2017-84938-P)Argentinian National Scientific and Technical Research CouncilProduction, Science and Technology Ministry of Santa Fe Province, Argentin

13Check_RNA: A tool to evaluate 13 C chemical shift assignments of RNA

Motivation: Chemical shifts (CS) are an important source of structural information of macromolecules such as RNA. In addition to the scarce availability of CS for RNA, the observed values are prone to errors due to a wrong re-calibration or miss assignments. Different groups have dedicated their efforts to correct CS systematic errors on RNA. Despite this, there are not automated and freely available algorithms for evaluating the referencing of RNA 13 C CS before their deposition to the BMRB or re-reference already deposited CS with systematic errors. Results: Based on an existent method we have implemented an open source python module to correct 13 C CS (from here on 13 C exp ) systematic errors of RNAs and then return the results in 3 formats including the nmrstar one.Fil: Icazatti Zuñiga, Alejandro Ariel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - San Luis. Instituto de Matemática Aplicada de San Luis "Prof. Ezio Marchi". Universidad Nacional de San Luis. Facultad de Ciencias Físico, Matemáticas y Naturales. Instituto de Matemática Aplicada de San Luis "Prof. Ezio Marchi"; ArgentinaFil: Martín, Osvaldo Antonio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - San Luis. Instituto de Matemática Aplicada de San Luis "Prof. Ezio Marchi". Universidad Nacional de San Luis. Facultad de Ciencias Físico, Matemáticas y Naturales. Instituto de Matemática Aplicada de San Luis "Prof. Ezio Marchi"; ArgentinaFil: Villegas, María Paula. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - San Luis. Instituto de Matemática Aplicada de San Luis "Prof. Ezio Marchi". Universidad Nacional de San Luis. Facultad de Ciencias Físico, Matemáticas y Naturales. Instituto de Matemática Aplicada de San Luis "Prof. Ezio Marchi"; ArgentinaFil: Szleifer, Igal. Northwestern University; Estados UnidosFil: Vila, Jorge Alberto. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - San Luis. Instituto de Matemática Aplicada de San Luis "Prof. Ezio Marchi". Universidad Nacional de San Luis. Facultad de Ciencias Físico, Matemáticas y Naturales. Instituto de Matemática Aplicada de San Luis "Prof. Ezio Marchi"; Argentin

Plant-insect interactions of the Passo das Tropas outcrop, Santa Maria Formation, southern Brazil (Late Ladinian)

.

Estimación de la carga de enfermedad para Colombia, 2010

Prólogo El concepto de carga de enfermedad resulta complejo de comprender aun en los ámbitos de la salud en que progresivamente cobra mayor relevancia a medida que se le reconoce y utiliza. No obstante, desde el año 1996, cuando Murray y López publican su definición por primera vez, se ha constituido como el conjunto más completo de estimaciones de mortalidad y morbilidad por edad, sexo y región nunca antes producido. Son múltiples los grupos a lo largo del mundo que han realizado esfuerzos para comprender, aprovechar, analizar y difundir este importante indicador. Para Colombia, es de suma importancia contar con estudios de este tipo para establecer marcos referenciales sobre los cuales estructurar planes de acción encaminados a identificar grupos poblacionales vulnerables. De esta manera será posible direccionar intervenciones sanitarias y establecer prioridades en los servicios e investigaciones en salud. Su importancia radica en la posibilidad de disponer de un indicador sintético que permita la toma de decisiones para el diseño ajustado de programas colectivos, la ubicación de la oferta de servicios y la orientación de la inversión en salud. Su mayor utilidad se relaciona con la integración de la discapacidad y la mortalidad en un único indicador.Bogot

Optic nerve and macular optical coherence tomography in recovered COVID-19 patients

Purpose: To investigate the peripapillary retinal nerve fiber layer thickness (RNFLT), macular RNFLT, ganglion cell layer (GCL), and inner plexiform layer (IPL) thickness in recovered COVID-19 patients compared to controls. Methods: Patients previously diagnosed with COVID-19 were included, while healthy patients formed the historic control group. All patients underwent an ophthalmological examination, including macular and optic nerve optical coherence tomography. In the case group, socio-demographic data, medical history, and neurological symptoms were collected. Results: One hundred sixty patients were included; 90 recovered COVID-19 patients and 70 controls. COVID-19 patients presented increases in global RNFLT (mean difference 4.3; CI95% 0.8 to 7.7), nasal superior (mean difference 6.9; CI95% 0.4 to 13.4), and nasal inferior (mean difference 10.2; CI95% 2.4 to 18.1) sectors of peripapillary RNFLT. Macular RNFL showed decreases in COVID-19 patients in volume (mean difference −0.05; CI95% −0.08 to −0.02), superior inner (mean difference −1.4; CI95% −2.5 to −0.4), nasal inner (mean difference −1.1; CI95% −1.8 to −0.3), and nasal outer (mean difference −4.7; CI95% −7.0 to −2.4) quadrants. COVID-19 patients presented increased GCL thickness in volume (mean difference 0.04; CI95% 0.01 to 0.07), superior outer (mean difference 2.1; CI95% 0.8 to 3.3), nasal outer (mean difference 2.5; CI95% 1.1 to 4.0), and inferior outer (mean difference1.2; CI95% 0.1 to 2.4) quadrants. COVID-19 patients with anosmia and ageusia presented an increase in peripapillary RNFLT and macular GCL compared to patients without these symptoms. Conclusions: SARS-CoV-2 may affect the optic nerve and cause changes in the retinal layers once the infection has resolved

Mutational Landscape of CEBPA in Mexican Pediatric Acute Myeloid Leukemia Patients: Prognostic Implications

BackgroundIn Mexico, the incidence of acute myeloid leukemia (AML) has increased in the last few years. Mortality is higher than in developed countries, even though the same chemotherapy protocols are used. CCAAT Enhancer Binding Protein Alpha (CEBPA) mutations are recurrent in AML, influence prognosis, and help to define treatment strategies. CEBPA mutational profiles and their clinical implications have not been evaluated in Mexican pediatric AML patients.Aim of the StudyTo identify the mutational landscape of the CEBPA gene in pediatric patients with de novo AML and assess its influence on clinical features and overall survival (OS).Materials and MethodsDNA was extracted from bone marrow aspirates at diagnosis. Targeted massive parallel sequencing of CEBPA was performed in 80 patients.ResultsCEBPA was mutated in 12.5% (10/80) of patients. Frameshifts at the N-terminal region were the most common mutations 57.14% (8/14). CEBPA biallelic (CEBPABI) mutations were identified in five patients. M2 subtype was the most common in CEBPA positive patients (CEBPAPOS) (p = 0.009); 50% of the CEBPAPOS patients had a WBC count > 100,000 at diagnosis (p = 0.004). OS > 1 year was significantly better in CEBPA negative (CEBPANEG) patients (p = 0.0001). CEBPAPOS patients (either bi- or monoallelic) had a significantly lower OS (p = 0.002). Concurrent mutations in FLT3, CSF3R, and WT1 genes were found in CEBPAPOS individuals. Their contribution to poor OS cannot be ruled out.ConclusionCEBPA mutational profiles in Mexican pediatric AML patients and their clinical implications were evaluated for the first time. The frequency of CEBPAPOS was in the range reported for pediatric AML (4.5–15%). CEBPA mutations showed a negative impact on OS as opposed to the results of other studies

La ciudad como experiencia de conocimiento: Nuevas metodologías de aprendizaje, iniciación de la investigación y extensión universitaria a partir de la historia urbana

Depto. de GeografíaDepto. de Historia Moderna y ContemporáneaDepto. de Historia del ArteFac. de Geografía e HistoriaFALSEsubmitte

La ciudad como experiencia de conocimiento: nuevas metodologías de aprendizaje, iniciación a la investigación y extensión universitaria a partir de la historia urbana

Memoria que recoge las actividades desarolladas en el proyecto de Innovación docente 327 de 2020 con título La ciudad como experiencia de conocimiento: nuevas metodologías de aprendizaje, iniciación a la investigación y extensión universitaria a partir de la historia urbana y dirigido por Rubén Pallol Trigueros

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

Objectives: The objective of this study was to estimate the association between tocilizumab or corticosteroids and the risk of intubation or death in patients with coronavirus disease 19 (COVID-19) with a hyperinflammatory state according to clinical and laboratory parameters. Methods: A cohort study was performed in 60 Spanish hospitals including 778 patients with COVID-19 and clinical and laboratory data indicative of a hyperinflammatory state. Treatment was mainly with tocilizumab, an intermediate-high dose of corticosteroids (IHDC), a pulse dose of corticosteroids (PDC), combination therapy, or no treatment. Primary outcome was intubation or death; follow-up was 21 days. Propensity score-adjusted estimations using Cox regression (logistic regression if needed) were calculated. Propensity scores were used as confounders, matching variables and for the inverse probability of treatment weights (IPTWs). Results: In all, 88, 117, 78 and 151 patients treated with tocilizumab, IHDC, PDC, and combination therapy, respectively, were compared with 344 untreated patients. The primary endpoint occurred in 10 (11.4%), 27 (23.1%), 12 (15.4%), 40 (25.6%) and 69 (21.1%), respectively. The IPTW-based hazard ratios (odds ratio for combination therapy) for the primary endpoint were 0.32 (95%CI 0.22-0.47; p < 0.001) for tocilizumab, 0.82 (0.71-1.30; p 0.82) for IHDC, 0.61 (0.43-0.86; p 0.006) for PDC, and 1.17 (0.86-1.58; p 0.30) for combination therapy. Other applications of the propensity score provided similar results, but were not significant for PDC. Tocilizumab was also associated with lower hazard of death alone in IPTW analysis (0.07; 0.02-0.17; p < 0.001). Conclusions: Tocilizumab might be useful in COVID-19 patients with a hyperinflammatory state and should be prioritized for randomized trials in this situatio